• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Radionuclide-Peptide Nucleic Acid in Diagnosis and Treatment of Pancreatic Cancer

        互联网

        464
        Cancer of the exocrine pancreas will attack an estimated 31,000 Americans in 2004, causing an estimated 30,000 deaths (1 ). Cancer of the exocrine pancreas (hereafter simply referred to as pancreatic cancer) occurs more frequently in African-Americans than in European-Americans. The disease progresses rapidly. Pancreatic cancer is usually refractory to treatment, with a median survival time of 12 mo. Overall, only 1% of patients live more than 5 yr after diagnosis. However, if the disease is diagnosed when it is localized, the 5-yr survival is approx 20% (2 ). It would be beneficial to detect pancreatic cancer at an early stage, when combination therapy with surgery and 5-fluorouracil (5-FU)-based chemotherapy might permit survival. In view of the current lack of a reliable method for early diagnosis, we propose noninvasive measurement of the oncogene expression profile of the cancer and subsequent ablation of those cells expressing the activating oncogenes.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序